{
    "organizations": [],
    "uuid": "c525bf3f413285f1b7ffabff6faf7a4e248fed77",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aileron-therapeutics-names-john-lo/brief-aileron-therapeutics-names-john-longenecker-as-interim-ceo-idUSFWN1SM1C2",
    "ord_in_thread": 0,
    "title": "BRIEF-Aileron Therapeutics Names John Longenecker As Interim CEO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Aileron Therapeutics Inc:\n* AILERON THERAPEUTICS ANNOUNCES CHANGES TO MANAGEMENT * AILERON THERAPEUTICS INC - JOHN P. LONGENECKER HAS BEEN NAMED INTERIM CHIEF EXECUTIVE OFFICER\n* AILERON THERAPEUTICS INC - JOSEPH A. YANCHIK III HAS RESIGNED AS PRESIDENT AND CHIEF EXECUTIVE OFFICER AND AS A MEMBER OF COâ€™S BOARD Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-16T04:15:00.000+03:00",
    "crawled": "2018-05-16T19:20:26.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "aileron",
        "therapeutic",
        "inc",
        "aileron",
        "therapeutic",
        "announces",
        "change",
        "management",
        "aileron",
        "therapeutic",
        "inc",
        "john",
        "longenecker",
        "named",
        "interim",
        "chief",
        "executive",
        "officer",
        "aileron",
        "therapeutic",
        "inc",
        "joseph",
        "yanchik",
        "iii",
        "resigned",
        "president",
        "chief",
        "executive",
        "officer",
        "member",
        "co",
        "board",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}